246 related articles for article (PubMed ID: 17237667)
1. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings.
Michna E; Jamison RN; Pham LD; Ross EL; Janfaza D; Nedeljkovic SS; Narang S; Palombi D; Wasan AD
Clin J Pain; 2007 Feb; 23(2):173-9. PubMed ID: 17237667
[TBL] [Abstract][Full Text] [Related]
2. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
Gupta A; Patton C; Diskina D; Cheatle M
Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
[TBL] [Abstract][Full Text] [Related]
5. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
[TBL] [Abstract][Full Text] [Related]
6. The role of urine toxicology in chronic opioid analgesic therapy.
Compton P
Pain Manag Nurs; 2007 Dec; 8(4):166-72. PubMed ID: 18036504
[TBL] [Abstract][Full Text] [Related]
7. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
[TBL] [Abstract][Full Text] [Related]
8. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
[TBL] [Abstract][Full Text] [Related]
9. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
10. Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.
Pesce A; West C; Gonzales E; Rosenthal M; West R; Mikel C; Almazan P; Latyshev S; Horn P
Pain Physician; 2012; 15(5):E687-92. PubMed ID: 22996862
[TBL] [Abstract][Full Text] [Related]
11. Urine toxicology testing in chronic pain management.
Cone EJ; Caplan YH
Postgrad Med; 2009 Jul; 121(4):91-102. PubMed ID: 19641275
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of abnormal urine drug screens among patients with chronic non-malignant pain treated with opioids.
Atluri S; Sudarshan G
Pain Physician; 2003 Oct; 6(4):407-9. PubMed ID: 16871289
[TBL] [Abstract][Full Text] [Related]
13. Interferences with urine drug screens.
Herring C; Muzyk AJ; Johnston C
J Pharm Pract; 2011 Feb; 24(1):102-8. PubMed ID: 21507878
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
15. Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine.
Wasan AD; Michna E; Janfaza D; Greenfield S; Teter CJ; Jamison RN
Pain Med; 2008 Oct; 9(7):918-23. PubMed ID: 18616432
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
Manchikanti L; Manchikanti KN; Pampati V; Cash KA
Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
[TBL] [Abstract][Full Text] [Related]
19. Validation of a screener and opioid assessment measure for patients with chronic pain.
Butler SF; Budman SH; Fernandez K; Jamison RN
Pain; 2004 Nov; 112(1-2):65-75. PubMed ID: 15494186
[TBL] [Abstract][Full Text] [Related]
20. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.
Michna E; Ross EL; Hynes WL; Nedeljkovic SS; Soumekh S; Janfaza D; Palombi D; Jamison RN
J Pain Symptom Manage; 2004 Sep; 28(3):250-8. PubMed ID: 15336337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
